Champions Oncology (CSBR) Short Interest Ratio & Short Volume → Guard Against the Coming Financial Upheaval (From Porter & Company) (Ad) Free CSBR Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipShort InterestSocial MediaSustainability Champions Oncology Short Interest DataCurrent Short Volume59,700 sharesPrevious Short Volume56,500 sharesChange Vs. Previous Month+5.66%Dollar Volume Sold Short$298,500.00Short Interest Ratio / Days to Cover16.1Last Record DateApril 30, 2024Outstanding Shares13,590,000 sharesFloat Size6,260,000 sharesShort Percent of Float0.95%Today's Trading Volume630 sharesAverage Trading Volume2,149 sharesToday's Volume Vs. Average29% Short Selling Champions Oncology ? Sign up to receive the latest short interest report for Champions Oncology and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCSBR Short Interest Over TimeCSBR Days to Cover Over TimeCSBR Percentage of Float Shorted Over Time Ad Porter & CompanyGuard Against the Coming Financial UpheavalAmerica’s Most Shocking Financial Story… Behind closed doors in D.C., there is a dark political and economic plot underway. That’s why if you have any savings in the bank or own any assets you want to protect, you must watch this new documentary before it’s too late.You can stream it for free right here. Champions Oncology Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202459,700 shares $298,500.00 +5.7%1.0%16.1 $5.00 4/15/202456,500 shares $284,195.00 -2.8%0.9%13.8 $5.03 3/31/202458,100 shares $284,690.00 -7.2%1.0%8.3 $4.90 3/15/202462,600 shares $342,422.00 -3.0%1.0%6 $5.47 2/29/202464,500 shares $365,070.00 +1.7%1.1%5.5 $5.66 2/15/202463,400 shares $359,478.00 -6.6%1.0%5.4 $5.67 Get the Latest News and Ratings for CSBR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Champions Oncology and its competitors with MarketBeat's FREE daily newsletter. 1/31/202467,900 shares $394,499.00 +6.1%1.1%5.5 $5.81 1/15/202464,000 shares $429,440.00 -5.7%1.1%5 $6.71 12/31/202367,900 shares $381,591.21 -16.8%1.1%6.1 $5.62 12/15/202381,600 shares $376,176.00 +16.9%1.4%8 $4.61 11/30/202369,800 shares $359,470.00 -1.7%1.2%7.9 $5.15 11/15/202371,000 shares $390,500.00 -2.6%1.2%8.7 $5.50 10/31/202372,900 shares $398,034.00 -6.9%0.7%8.7 $5.46 10/15/202378,300 shares $481,545.00 +5.4%0.8%9.2 $6.15 9/30/202374,300 shares $461,403.00 +25.3%0.7%9.1 $6.21 9/15/202359,300 shares $311,325.00 +3.0%0.6%7.4 $5.25 8/31/202357,600 shares $385,920.00 -22.8%0.6%7 $6.70 8/15/202374,600 shares $484,154.00 -5.1%1.4%8.4 $6.49 7/31/202378,600 shares $510,900.00 +14.9%1.5%8.6 $6.50 7/15/202368,400 shares $452,151.36 +1.5%1.3%8 $6.61 6/30/202367,400 shares $430,012.00 -4.3%1.2%6.9 $6.38 6/15/202370,400 shares $387,904.00 -25.6%1.3%6.9 $5.51 5/31/202394,600 shares $463,540.00 +67.7%1.7%8.9 $4.90 5/15/202356,400 shares $250,416.00 -0.5%1.0%5.2 $4.44 4/30/202356,700 shares $278,964.00 -10.6%1.0%5.3 $4.92 4/15/202363,400 shares $304,320.00 +6.0%1.2%5.2 $4.80 3/31/202359,800 shares $240,396.00 +4.0%1.1%4.6 $4.02 3/15/202357,500 shares $235,750.00 -1.2%1.1%3.5 $4.10 2/28/202358,200 shares $270,630.00 +3.2%1.1%2.6 $4.65 2/15/202356,400 shares $232,368.00 +0.5%1.0%2.5 $4.12 1/31/202356,100 shares $230,571.00 +6.3%1.0%2.4 $4.11 1/15/202352,800 shares $227,040.00 -14.0%1.0%2.3 $4.30 12/30/202261,400 shares $276,914.00 -2.4%1.1%3 $4.51 12/15/202262,900 shares $345,950.00 -2.5%1.2%3.2 $5.50 11/30/202264,500 shares $445,050.00 +7.0%1.2%7.2 $6.90 11/15/202260,300 shares $386,523.00 -9.3%1.1%6.6 $6.41 10/31/202266,500 shares $461,510.00 -1.6%1.2%7.2 $6.94 10/15/202267,600 shares $508,352.00 -2.5%1.3%7.5 $7.52 9/30/202269,300 shares $519,750.00 -10.9%1.1%6.8 $7.50 9/15/202277,800 shares $680,750.00 +22.7%1.3%7.9 $8.75What’s Really Next for America… (Ad)Millions of Unsuspecting Americans Could be Wiped Out… Yet those who watch this bombshell exposé and prepare before it’s too late could have the chance to protect their financial future and grow their wealth significantly.Click here to stream this controversial exposé now. CSBR Short Interest - Frequently Asked Questions What is Champions Oncology's current short interest? Short interest is the volume of Champions Oncology shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 59,700 shares of CSBR short. 0.95% of Champions Oncology's shares are currently sold short. Learn More on Champions Oncology's current short interest. What is a good short interest ratio for Champions Oncology? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CSBR shares currently have a short interest ratio of 16.0. Learn More on Champions Oncology's short interest ratio. Which institutional investors are shorting Champions Oncology? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Champions Oncology: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Champions Oncology? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.95% of Champions Oncology's floating shares are currently sold short. Is Champions Oncology's short interest increasing or decreasing? Champions Oncology saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 59,700 shares, an increase of 5.7% from the previous total of 56,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Champions Oncology's float size? Champions Oncology currently has issued a total of 13,590,000 shares. Some of Champions Oncology's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Champions Oncology currently has a public float of 6,260,000 shares. How does Champions Oncology's short interest compare to its competitors? 0.95% of Champions Oncology's shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Champions Oncology: Genenta Science S.p.A. (0.03%), Cidara Therapeutics, Inc. (2.04%), Ikena Oncology, Inc. (5.99%), Aligos Therapeutics, Inc. (1.11%), Turnstone Biologics Corp. (5.22%), Elutia Inc. (0.20%), Atara Biotherapeutics, Inc. (9.87%), AVROBIO, Inc. (0.42%), Instil Bio, Inc. (0.19%), Precision BioSciences, Inc. (9.31%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Champions Oncology stock? Short selling CSBR is an investing strategy that aims to generate trading profit from Champions Oncology as its price is falling. CSBR shares are trading down $0.15 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Champions Oncology? A short squeeze for Champions Oncology occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CSBR, which in turn drives the price of the stock up even further. How often is Champions Oncology's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CSBR, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Genenta Science Short Squeeze Entera Bio Short Squeeze Cidara Therapeutics Short Squeeze Ikena Oncology Short Squeeze Aligos Therapeutics Short Squeeze Turnstone Biologics Short Squeeze Elutia Short Squeeze Atara Biotherapeutics Short Squeeze AVROBIO Short Squeeze Instil Bio Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CSBR) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsElon’s New Device is About to Shock the WorldInvestorPlaceCharles Payne Demystifies OptionsUnstoppable ProsperityNot Trump. Not Biden. But ___________.The Freeport SocietyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressGold ManiaStansberry ResearchThe only AI company you should be looking atBehind the Markets